Differences

This shows you the differences between two versions of the page.

--- jc [2024/08/06 13:06] – admin
+++ jc [2024/11/16 21:11] (current) – admin
@@ Line 7: / Line 7: @@
       * **Finding:** VL had better first-pass success than DL
   * CARDS
+    * [[https://doi.org/10.1016/j.resuscitation.2024.110360 | IV vs IO for OHCA]]
+      * Finding: IV assoc with better survival and neuro fav outcomes
     * [[https://doi.org/10.1056/NEJMoa2307983 | MINT: Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia]]
       * **Finding**: In patients with acute myocardial infarction and anemia, a liberal transfusion strategy did not significantly reduce the risk of recurrent myocardial infarction or death at 30 days.
@@ Line 18: / Line 20: @@
       * **Finding**: Impella CP reduces mortality
       * **Significance**: First trial to show mortality benefit from MCS
+  * PULM
+    * [[ https://www.nejm.org/doi/full/10.1056/NEJMoa2406673 | Depemokimab]]
+    * [[https://www.nejm.org/doi/full/10.1056/NEJMoa2409712 | Inebilizumab for Treatment of IgG4-Related Disease]]
   * GI
     * [[https://doi.org/10.1097/HEP.0000000000000817 | Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis]]

ewrobbins.com